Replies to post #20032 on NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

I hate to admit this, but I sold my $5 at cost shares yesterday. I kept everything else. The failed breakout does mean the ball is temporarily in the shorts hands. I will be loading up once we have an established bottom.

[Pyrrhonian]

He might just say yet again it's a reflection of the state of all oversold biotechs in late stage clinical development. And yeah it doesn't matter. Something like that ;)

[Ready4bluesky]

Anyone who thinks share price doesn't matter for a company like Northwest is either intentionally trying to trick folks or really doesn't have a clue. Nwbo survives with equity capital raises and the depressed share price could severely limit their ability to continue funding Cognate at current levels.

[H2R]

It is hard to see the PPS go down, even more so when the actual news are good and no bad news (say a failed trial, a negative patient story, a new side effect) emerge.

That's when I have to remind myself of why I invest in NWBO, what is my timeline, is 'the story' (à la Peter Lynch) relevant, was there a substantive change in DD, etc. Then what market cap is reasonable within one year, two years. Does that work for me?
That's when I check on my investment discipline.

So even if it's painful to watch this stock PPS go down, when I put it in perspective, I keep Long. Definitely long. If I did not, and in a couple months (this fall is what LP announced last) the HE is PR'ed (or some Direct news), and the PPS jumps up, I would kick myself.

To each his own. This past couple of weeks have been painful but do not change my opinion.

GLT all Longs and Cancer Patients :)